Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164–172 (2023).
Jafar, T. H. et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann. Intern. Med. 135, 73–87 (2001).
Westhoff, J. H. et al. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 52, 123–129 (2008).
Mogi, M. Effect of renin-angiotensin system on senescence. Geriatr. Gerontol. Int. 20, 520–525 (2020).
Kitada, K. et al. Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy. J. Diabetes Complications 28, 604–611 (2014).
Wang, Y., Jin, M., Cheng, C. K. & Li, Q. Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives. Front. Endocrinol. (Lausanne) 14, 1238927 (2023).
Buchanan, S., Combet, E., Stenvinkel, P. & Shiels, P. G. Klotho, aging, and the failing kidney. Front. Endocrinol. (Lausanne) 11, 560 (2020).
Thielemans, R. et al. Unveiling the hidden power of uromodulin: a promising potential biomarker for kidney diseases. Diagnostics (Basel) 13, 3077 (2023).
Iacobazzi, D., Alvino, V. V., Caputo, M. & Madeddu, P. Accelerated cardiac aging in patients with congenital heart disease. Front. Cardiovasc. Med. 9, 892861 (2022).
Cortes-Canteli, M. & Iadecola, C. Alzheimer’s disease and vascular aging: JACC Focus Seminar. J. Am. Coll. Cardiol. 75, 942–951 (2020).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41581-024-00842-0